ATAD3A
Basic information
Region (hg38): 1:1512162-1534685
Links
Phenotypes
GenCC
Source:
- pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal (Strong), mode of inheritance: AR
- Harel-Yoon syndrome (Definitive), mode of inheritance: Semidominant
- Harel-Yoon syndrome (Moderate), mode of inheritance: AD
- pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal (Moderate), mode of inheritance: AR
- Harel-Yoon syndrome (Strong), mode of inheritance: AD
- Harel-Yoon syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Harel-Yoon syndrome; Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Cardiovascular; Craniofacial; Musculoskeletal; Ophthalmologic; Neurologic; Pulmonary | 27640307; 28549128; 29053797 |
ClinVar
This is a list of variants' phenotypes submitted to
- Harel-Yoon syndrome (2 variants)
- Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal (2 variants)
- Congenital cerebellar hypoplasia (1 variants)
- not provided (1 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATAD3A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 30 | 36 | ||||
missense | 136 | 154 | ||||
nonsense | 7 | |||||
start loss | 1 | |||||
frameshift | 5 | |||||
inframe indel | 5 | |||||
splice donor/acceptor (+/-2bp) | 6 | |||||
splice region | 8 | 6 | 2 | 16 | ||
non coding | 10 | 11 | 24 | |||
Total | 4 | 16 | 155 | 42 | 21 |
Highest pathogenic variant AF is 0.0000197
Variants in ATAD3A
This is a list of pathogenic ClinVar variants found in the ATAD3A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-1512268-C-T | Uncertain significance (Nov 15, 2022) | |||
1-1512270-T-A | Likely pathogenic (Sep 12, 2023) | |||
1-1512287-A-C | Uncertain significance (Mar 31, 2022) | |||
1-1512287-A-G | Harel-Yoon syndrome | Benign/Likely benign (Aug 01, 2024) | ||
1-1512296-G-A | Inborn genetic diseases | Uncertain significance (Jan 22, 2024) | ||
1-1512305-G-A | Inborn genetic diseases | Uncertain significance (Jul 05, 2023) | ||
1-1512307-T-A | Likely benign (Apr 01, 2023) | |||
1-1512313-C-T | Benign (Dec 14, 2017) | |||
1-1512320-C-T | Uncertain significance (Jan 21, 2022) | |||
1-1512338-C-T | Uncertain significance (May 06, 2022) | |||
1-1512374-G-C | Uncertain significance (Dec 16, 2022) | |||
1-1512376-G-C | not specified | Benign (Jan 24, 2024) | ||
1-1512393-C-T | Uncertain significance (Sep 22, 2022) | |||
1-1512396-C-A | Inborn genetic diseases | Uncertain significance (Mar 25, 2024) | ||
1-1512399-A-G | Harel-Yoon syndrome | Uncertain significance (Oct 19, 2021) | ||
1-1512412-C-G | Inborn genetic diseases | Uncertain significance (Jan 02, 2024) | ||
1-1512418-C-G | Harel-Yoon syndrome | Uncertain significance (-) | ||
1-1512423-C-T | Harel-Yoon syndrome | Uncertain significance (Aug 25, 2022) | ||
1-1512426-C-T | Harel-Yoon syndrome • not specified • Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal | Conflicting classifications of pathogenicity (Apr 04, 2024) | ||
1-1512436-G-A | Likely benign (Dec 27, 2017) | |||
1-1512441-CCGCCAAGGCGGCG-C | Uncertain significance (Dec 31, 2019) | |||
1-1512447-A-T | Inborn genetic diseases | Uncertain significance (Jan 19, 2024) | ||
1-1512453-C-T | Inborn genetic diseases | Uncertain significance (Jul 11, 2024) | ||
1-1512459-A-C | Inborn genetic diseases | Uncertain significance (Dec 17, 2021) | ||
1-1512464-G-C | Inborn genetic diseases | Uncertain significance (Aug 09, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ATAD3A | protein_coding | protein_coding | ENST00000378755 | 16 | 22537 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.09e-9 | 0.987 | 125701 | 0 | 41 | 125742 | 0.000163 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0126 | 401 | 402 | 0.998 | 0.0000293 | 4053 |
Missense in Polyphen | 77 | 101.61 | 0.75776 | 1122 | ||
Synonymous | -0.993 | 188 | 171 | 1.10 | 0.0000126 | 1285 |
Loss of Function | 2.35 | 19 | 33.7 | 0.564 | 0.00000194 | 368 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000595 | 0.000589 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000467 | 0.0000462 |
European (Non-Finnish) | 0.000145 | 0.000141 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Essential for mitochondrial network organization, mitochondrial metabolism and cell growth at organism and cellular level. May play an important role in mitochondrial protein synthesis. May also participate in mitochondrial DNA replication. May bind to mitochondrial DNA D-loops and contribute to nucleoid stability. Required for enhanced channeling of cholesterol for hormone-dependent steroidogenesis. {ECO:0000269|PubMed:17210950, ECO:0000269|PubMed:20154147, ECO:0000269|PubMed:22453275}.;
- Disease
- DISEASE: Harel-Yoon syndrome (HAYOS) [MIM:617183]: A syndrome characterized by global developmental delay, hypotonia, intellectual disability, and axonal neuropathy. Some patients have optic atrophy and hypertrophic cardiomyopathy. HAYOS inheritance can be autosomal dominant or autosomal recessive. {ECO:0000269|PubMed:27640307}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- loftool
- 0.0950
- rvis_EVS
- 0.12
- rvis_percentile_EVS
- 62.21
Haploinsufficiency Scores
- pHI
- 0.301
- hipred
- N
- hipred_score
- 0.407
- ghis
- 0.518
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.735
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Atad3a
- Phenotype
- muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; skeleton phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- regulation of cell growth;mitochondrion organization;negative regulation of apoptotic process
- Cellular component
- mitochondrion;mitochondrial inner membrane;integral component of membrane;mitochondrial nucleoid
- Molecular function
- ATP binding;zinc ion binding